Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

The order, signed in October 2023, required companies building powerful AI systems to share their safety test results with ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

The company fulfilled requests from Israel’s military for more access to AI tools, as it sought to compete with Amazon, ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.

Mistral, the French AI lab, is working toward an initial public offering, co-founder and CEO Arthur Mensch said in an ...

Google DeepMind AI for Science Scholarships are now available, offering African students the opportunity to pursue postgraduate degrees ...

A string of startups are racing to build models that can produce better and better software. They claim it’s the shortest path to AGI.

Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...

European artificial intelligence champion Mistral AI is “not for sale” and instead is working toward an initial public offering, according to Chief Executive Officer Arthur Mensch.